Lichen Planus Induced by Stevens Johnson Syndrome
Published: 2023-02-27
Page: 14-19
Issue: 2023 - Volume 6 [Issue 1]
Zoubida Mehsas *
Department of Dermatology-Venereology, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.
Soukaina Sektaoui
Department of Dermatology-Venereology, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.
Marwa Asermouh
Department of Dermatology-Venereology, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.
Kaoutar Znati
Department of Anatomopathology, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.
Meriame Meziane
Department of Dermatology-Venereology, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.
Karima Senouci
Department of Dermatology-Venereology, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
The present study reports the appearance of lichen lesions with genital and nail involvement 2 months after the onset of a Stevens-Johnson syndrome (SJS) associated with lamotrigine use. A chronic inflammatory disorder called lichen planus (LP) most frequently affects middle-aged adults. LP can affect the skin or mucous membranes, such as the conjunctiva, vulvovaginal, esophageal, and laryngeal mucosa. A 23-year-old patient was hospitalized in dermatology for SJS that occurred 9 days after taking lamotrigine for treatment of severe depression. The occurrence of cutaneous lichen lesions on the site of a healed dermatosis has been widely reported under the name of Wolf's isotopic response. This isotopic response refers to the appearance of a new dermatosis on the site of an old healed dermatosis.
Keywords: Lichen planus, stevens johnson syndrome, nail lichen
How to Cite
Downloads
References
Farzam Gorouhi, Parastoo Davari, and Nasim Fazel. Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis. the Scientific World Journal. 2014; 22.
Article ID 742826
I Kolm et al. Lichenoid drug eruption following intravenous application of orally formulated diamorphine, a semisynthetic heroin. Case Rep Dermatol. 2013;5(2): 176–180.
Roni P. Dodiuk-Gad et al. Stevens–johnson syndrome and toxic epidermal necrolysis: An update. Am J Clin Dermatol. DOI 10.1007/s40257-015-0158-0
Wakana I et al. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in Their cytolytic granules. Am J Pathol. 2003163(1):261–268.
Ziemer CM, Miedema J, Smith CJ, Liu Z, Thomas NE, Googe PB. Immunohistochemical Expression of PD-L1 Is Increased in Lesional Epidermal Keratinocytes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. The American Journal of Dermatopathology. 2021;43(4):318–320.
Saka B et al. Lichen plan cutané sur cicatrices d’un syndrome de Stevens-Johnson : réponse isotopique de Wolf. Ann Dermatol Venereol; 2019.
Ruocco V, Ruocco E, Brunetti G, Russo T, Gambardella A, Wolf R. Wolf’s post-herpetic isotopic response: infections, tumors, and immune disorders arising on the site of healed herpetic infection. Clin Dermatol 2014;32:561-8.
Ise M, Tanese K, Adachi T, Du W, Amagai M, Ohyama M. Posther- petic Wolf’s isotopic response: possible contribution of resident memory T cells to the pathogenesis of lichenoid reaction. Br J Dermatol. 2015;173:1331.
Alamri A, Alsenaid A, Ruzicka T, Wolf R. Wolf’s isotopic response: Lichen planus patterns on non-segmental muco-cutaneous vitiligo. Eur J Dermatol 2018;28: 229-30.
Worsnop F, Wee J, Natkunarajah J, Moosa Y, Marsden R. Reaction to biological drugs: Infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus. Clin Exp Dermatol. 2012;37(8):879-881. DOI:10.1111/j.1365-2230.2012.04357